Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540761 · ClinicalTrials.gov registry record · NA
Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique
A NA study of Coronary Arteriosclerosis, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 320
- Enrollment target
- 3
- Study locations
NCT00540761: Active NA study of Coronary Arteriosclerosis, sponsored by Massachusetts General Hospital.
NCT00540761 is a NA study of Coronary Arteriosclerosis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 320 participants, below the 689-participant average among 11 other Coronary Arteriosclerosis trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540761, a NA study of Coronary Arteriosclerosis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
- 3
- Study locations
Study Summary
Atherosclerosis, a condition in which fatty deposits of plaque build up along the inner walls of arteries, is a condition that may increase the risk of having a heart attack. Previous studies have shown that the presence of a specific kind of plaque, known as vulnerable plaque, is often found in people who have had a heart attack. This study will use a new imaging technique called optical frequency domain imaging (OFDI) to examine the presence of vulnerable plaques in people with coronary artery disease.
Primary Outcome
Number of subjects with vulnerable plaques
Conditions Studied
Interventions
- DEVICE OFDI imaging
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
- Lahey Clinic - Burlington
New York
- Columbia Presbyterian Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2007-07-25 |
| Est. Completion | 2028-12 |
| Phase | NA |
What the registry record for NCT00540761 still lists
NCT00540761 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 689-participant average among 11 other Coronary Arteriosclerosis trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Coronary Arteriosclerosis appearing as the primary indexed condition, and to 1 intervention - of which OFDI imaging is the first listed.
NCT00540761 reports a single indexed study location in Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT00540761 about?
NCT00540761 is a clinical study titled "Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique". Atherosclerosis, a condition in which fatty deposits of plaque build up along the inner walls of arteries, is a condition that may increase the risk of having a heart attack. Previous studies have shown that the presence of a specific kind of plaque, known as vulnerable plaque, is often found in peo...
What is the current status of trial NCT00540761?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2007-07-25. Estimated completion is 2028-12.
What conditions does trial NCT00540761 study?
This clinical trial studies the following conditions: Coronary Arteriosclerosis.
What interventions are being tested in trial NCT00540761?
The interventions under investigation include: OFDI imaging (DEVICE).
Who is sponsoring clinical trial NCT00540761?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00540761 being conducted?
This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Arteriosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00540761's enrollment target sits among peer trials
320 7th of 11 higher than 5 of 11 other Coronary Arteriosclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Arteriosclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
COMPLETED · NA
-
HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
COMPLETED · NA
-
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
COMPLETED · NA
-
Multidisciplinary Inpatient Palliative Care Intervention
COMPLETED · NA
-
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI